NSAM
North Star Asset Management Portfolio holdings
AUM
$2.36B
This Quarter Return
+8.63%
1 Year Return
+14.42%
3 Year Return
+63.82%
5 Year Return
+104.72%
10 Year Return
+249.93%
AUM
$2.36B
AUM Growth
+$2.36B
(+7.9%)
Cap. Flow
+$32.7M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
24.4%
Holding
354
New
28
Increased
133
Reduced
109
Closed
10
Top Buys
| 1 |
Illinois Tool Works
ITW
|
$8.26M |
| 2 |
Cadence Design Systems
CDNS
|
$3.84M |
| 3 |
Fastenal
FAST
|
$3.23M |
| 4 |
Apple
AAPL
|
$2.53M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
$2.08M |
Top Sells
| 1 |
Schwab US Broad Market ETF
SCHB
|
$5.83M |
| 2 |
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
$2.84M |
| 3 |
Advanced Micro Devices
AMD
|
$2.13M |
| 4 |
FedEx
FDX
|
$1.61M |
| 5 |
SPDR Gold Trust
GLD
|
$1.4M |
Sector Composition
| 1 | Technology | 32.91% |
| 2 | Healthcare | 13.76% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 6.95% |
| 5 | Consumer Discretionary | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Kraft Heinz
KHC
$30.8B
| $406K | 0.02% |
15,707
-111
| -0.7% | -$2.87K |
|
227
Medtronic
MDT
$120B
| $405K | 0.02% |
4,644
-318
| -6% | -$27.7K |
|
228
Regeneron Pharmaceuticals
REGN
$61.3B
| $387K | 0.02% |
+737
| New | +$387K |
|
229
MGIC Investment
MTG
$6.42B
| $375K | 0.02% |
+13,454
| New | +$375K |
|
230
General Mills
GIS
$26.4B
| $369K | 0.02% |
7,119
+1,540
| +28% | +$79.8K |
|
231
Enphase Energy
ENPH
$4.84B
| $367K | 0.02% |
9,259
-1,710
| -16% | -$67.8K |
|
232
Honeywell
HON
$138B
| $366K | 0.02% |
1,573
| – | – |
|
233
EPAM Systems
EPAM
$9.73B
| $362K | 0.02% |
2,050
+300
| +17% | +$53K |
|
234
Constellation Energy
CEG
$96B
| $359K | 0.02% |
1,111
| – | – |
|
235
Franklin Resources
BEN
$13.2B
| $352K | 0.01% |
14,770
| – | – |
|
236
Sprott Physical Gold and Silver Trust
CEF
$6.42B
| $346K | 0.01% |
11,500
| – | – |
|
237
Deere & Co
DE
$129B
| $327K | 0.01% |
642
+152
| +31% | +$77.4K |
|
238
Zimmer Biomet
ZBH
$20.8B
| $327K | 0.01% |
3,580
| – | – |
|
239
Unilever
UL
$156B
| $321K | 0.01% |
+5,254
| New | +$321K |
|
240
Enbridge
ENB
$105B
| $314K | 0.01% |
6,929
| – | – |
|
241
Masimo
MASI
$7.48B
| $313K | 0.01% |
1,860
-50
| -3% | -$8.41K |
|
242
Fortive
FTV
$16B
| $308K | 0.01% |
5,915
| – | – |
|
|
IIF
243
Morgan Stanley India Investment Fund
IIF
$251M
| $306K | 0.01% |
10,839
-70
| -0.6% | -$1.98K |
|
244
Akero Therapeutics
AKRO
$3.63B
| $304K | 0.01% |
+5,700
| New | +$304K |
|
245
AstraZeneca
AZN
$249B
| $300K | 0.01% |
+4,300
| New | +$300K |
|
246
American Express
AXP
$230B
| $299K | 0.01% |
937
-393
| -30% | -$125K |
|
247
Morgan Stanley
MS
$238B
| $297K | 0.01% |
2,107
+50
| +2% | +$7.04K |
|
248
Whirlpool
WHR
$5.06B
| $291K | 0.01% |
2,870
| – | – |
|
249
Duke Energy
DUK
$94.8B
| $291K | 0.01% |
2,464
+2
| +0.1% | +$236 |
|
250
Dutch Bros
BROS
$9.27B
| $287K | 0.01% |
+4,200
| New | +$287K |
|